Developmentally regulated GTP-binding protein 2 ameliorates EAE by suppressing the development of TH17 cells

Copyright © 2013 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 150(2014), 2 vom: 01. Feb., Seite 225-35
1. Verfasser: Ko, Myoung Seok (VerfasserIn)
Weitere Verfasser: Kim, Hyo Jeong, Kim, Hong Kyung, Yoon, Nal Ae, Lee, Unn Hwa, Lee, Sang Chul, Chung, Dae Kyun, Lee, Byung Ju, Suh, Jae Hee, Cho, Wha Ja, Park, Jeong Woo
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2014
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, Non-U.S. Gov't DRG2 EAE IL-6 NF-κB PPARγ T(H)17 Co-Repressor Proteins Cytokines mehr... Inflammation Mediators Interleukin-6 NF-kappa B PPAR gamma developmentally regulated GTP-binding protein 149371-72-2 GTP-Binding Proteins EC 3.6.1.-
LEADER 01000naa a22002652 4500
001 NLM234842709
003 DE-627
005 20231224102130.0
007 cr uuu---uuuuu
008 231224s2014 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.clim.2013.12.004  |2 doi 
028 5 2 |a pubmed24n0782.xml 
035 |a (DE-627)NLM234842709 
035 |a (NLM)24463315 
035 |a (PII)S1521-6616(13)00323-9 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Ko, Myoung Seok  |e verfasserin  |4 aut 
245 1 0 |a Developmentally regulated GTP-binding protein 2 ameliorates EAE by suppressing the development of TH17 cells 
264 1 |c 2014 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 08.04.2014 
500 |a Date Revised 05.02.2014 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a Copyright © 2013 Elsevier Inc. All rights reserved. 
520 |a Developmentally regulated GTP-binding protein 2 (DRG2) represents a novel subclass of GTP-binding proteins. We here report that transgenic overexpression of DRG2 in mice ameliorates experimental autoimmune encephalomyelitis (EAE), a murine model of multiple sclerosis (MS). The protective effect of DRG2 in EAE was mediated by the inhibition of the development of T(H)17 cells. DRG2 enhanced the activity of PPARγ, which led to an inhibition of the nuclear factor kappa B (NF-κB) activity and IL-6 production in antigen presenting cells and an inhibition of the development of T(H)17 cells. Our results demonstrate that DRG2 is an essential modulator of EAE 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 4 |a DRG2 
650 4 |a EAE 
650 4 |a IL-6 
650 4 |a NF-κB 
650 4 |a PPARγ 
650 4 |a T(H)17 
650 7 |a Co-Repressor Proteins  |2 NLM 
650 7 |a Cytokines  |2 NLM 
650 7 |a Inflammation Mediators  |2 NLM 
650 7 |a Interleukin-6  |2 NLM 
650 7 |a NF-kappa B  |2 NLM 
650 7 |a PPAR gamma  |2 NLM 
650 7 |a developmentally regulated GTP-binding protein  |2 NLM 
650 7 |a 149371-72-2  |2 NLM 
650 7 |a GTP-Binding Proteins  |2 NLM 
650 7 |a EC 3.6.1.-  |2 NLM 
700 1 |a Kim, Hyo Jeong  |e verfasserin  |4 aut 
700 1 |a Kim, Hong Kyung  |e verfasserin  |4 aut 
700 1 |a Yoon, Nal Ae  |e verfasserin  |4 aut 
700 1 |a Lee, Unn Hwa  |e verfasserin  |4 aut 
700 1 |a Lee, Sang Chul  |e verfasserin  |4 aut 
700 1 |a Chung, Dae Kyun  |e verfasserin  |4 aut 
700 1 |a Lee, Byung Ju  |e verfasserin  |4 aut 
700 1 |a Suh, Jae Hee  |e verfasserin  |4 aut 
700 1 |a Cho, Wha Ja  |e verfasserin  |4 aut 
700 1 |a Park, Jeong Woo  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 150(2014), 2 vom: 01. Feb., Seite 225-35  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:150  |g year:2014  |g number:2  |g day:01  |g month:02  |g pages:225-35 
856 4 0 |u http://dx.doi.org/10.1016/j.clim.2013.12.004  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 150  |j 2014  |e 2  |b 01  |c 02  |h 225-35